Peroxisome proliferator-activated receptor γ inhibits the migration of dendritic cells: Consequences for the immune response

Journal of Immunology

Volumn 170, Issue 10, 2003, Pages 5295-5301

  Angeli, Véronique ^a   Hammad, Hamida ^b   Staels, Bart ^a   Capron, Monique ^a   Lambrecht, Bart N ^b   Trottein, François ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; BLOOD VESSEL WALL; CELL MIGRATION; CONTACT ALLERGY; DENDRITIC CELL; DRUG EFFECT; EPIDERMIS CELL; EPITHELIUM CELL; GLUCOSE HOMEOSTASIS; IMMUNE RESPONSE; LANGERHANS CELL; LIPID METABOLISM; LYMPHOID ORGAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 0038221307     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.10.5295     Document Type: Article

References (65)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Steinman, R. M., M. Pack, and K. Inaba. 1997. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156:25.
3. Kimber, I., R. J. Dearman, M. Cumberbatch, and R. J. Huby. 1998. Langerhans cells and chemical allergy. Curr. Opin. Immunol. 10:614.
4. Moodycliffe, A. M., I. Kimber, and M. Norval. 1992. Role of TNFα in ultraviolet β light-induced dendritic cell migration and suppression of contact hypersensitivity. Immunology. 81:79.
5. Schwarzenberger, K., and M. C. Udey. 1996. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J. Invest. Dermatol. 106:553.
6. Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term culture. J. Exp. Med. 185:317.
7. 4 transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103:757.
8. 2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100:1354.
9. Takayama, K., H. Yokozeki, M. Ghoreishi, T. Satoh, I. Katayama, T. Umeda, and K. Nishioka. 1999. IL-4 inhibits the migration of human Langerhans cells through the downregulation of TNF receptor II expression. J. Invest. Dermatol. 113:541.
10. Wang, B., L. Zhuang, H. Fujisawa, G. A. Shinder, C. Feliciani, G. M. Shivji, H. Suzuki, P. Amerio, P. Toto, and D. N. Saunder. 1999. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J. Immunol. 162:277.
11. 2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J. Exp. Med. 193:1138.
12. Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, et al. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835.
13. Huang, J., T., J. S. Welch, M. Ricote, C. J. Binder, T. M. Willson, C. Kelly, J. L. Witztum, C. D. Funk, D. Conrad, and C. K. Glass. 1999. Interleukin-4-dependent production of PPARγ ligands in macrophages by 12/15-lipoxygenase. Nature 400:378.
14. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83:813.
15. Nagy, L., P. Tontonoz, J., G. Alvarez, H. Chen, and R. M. Evans. 1998. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93:229.
16. Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for PPARγ. J. Biol. Chem. 270:12953.
17. Kliewer, S. A., K. Umesono, D. J. Noonan, R. A. Heyman, and R. M. Evans. 1992. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358:771.
18. Lemberger, T., B. Desvergne, and W. Wahli. 1996. PPARs: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell. Dev. Biol. 12:335.
19. Pineda Torra, I., P. Gervois, and B. Staels. 1999. PPARα in metabolic disease, inflammation, atherosclerosis and aging. Curr. Opin. Lipidol. 10:151.
20. Goetze, S., X. P. Xi, H. Kawano, T. Gotlibowski, E. Fleck, W. A. Hsueh, and R. E. Law. 1999. PPARγ-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 33:798.
21. Kintscher, U., S. Goetze, S. Wakino, S. Kim, S. Nagpal, R. A. Chandraratna, K. Graf, E. Fleck, W. A. Hsueh, and R. E. Law. 2000. Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes. Eur. J. Pharmacol. 401:259.
22. Staels, B., W. Koenig, A. Habib, R. Merval, M. Lebret, I. P. Torra, P. Delerive, A. Fadel, G. Chinetti, J. C. Fruchart, et al. 1998. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature 393:790.
23. Jiang, C., A. T. Ting, and B. Seed. 1998. PPARγ agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82.
24. Ricote, M., A. C. Li., T. M. Willson, C. J. Kelly, and C. K. Glass. 1998. The PPARγ is a negative regulator of macrophage activation. Nature 391:79.
25. Issemann, I., and S. Green. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645.
26. Braissant, O., F. Foufelle, C. Scotto, M. Dauca, and W. Wahli. 1996. Differenfial expression of PPARs: tissue distribution of PPARα, β, and γ in the adult rat. Endocrinology 137:354.
27. Barak, Y., D. Liao, W. He, E. S. Ong, M. C. Nelson, J. M. Olefsky, R. Boland, and R. M. Evans. 2002. Effects of PPARδ on placentation, adiposity, and colorectal cancer. Proc. Natl. Acad. Sci. USA 99:303.
28. Marx, N., T. Bourcier, G. K. Sukhova, P. Libby, and J. Plutzky. 1999. PPARγ activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARγ as a potential mediator in vascular disease. Arterioscler. Thromb. Vasc. Biol. 19:546.
29. Cunard, R., D. DiCampli, D. C. Archer, J. L. Stevenson, M. Ricote, C. K. Glass, and C. J. Kelly. 2002. WY14,643, a PPARα ligand has profound effects on immune responses in vivo. J. Immunol. 169:6806.
30. Tontonoz, P., L. Nagy, J. G. Alvarez, V. A. Thomazy, and R. M. Evans. 1998. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93:241.
31. Chinetti, G., S. Griglio, M. Antonucci, I. P. Torra, P. Delerive, Z. Majd, J. C. Fruchart, J. Chapman, J. Najib, and B. Staels. 1998. Activation of PPARα and PPARγ induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem. 273:25573.
32. Marx, N., G. Sukhova, C. Murphy, P. Libby, and J. Plutzky. 1998. Macrophages in human atheroma contain PPARγ: differentiation-dependent PPARγ expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro. Am. J. Pathol. 153:17.
33. Padilla, J., K. Kaur, S. G. Harris, and R. P. Phipps. 2000. PPARγ mediated regulation of normal and malignant B lineage cells. Ann. NY Acad. Sci. 905:97.
34. Clark, R. B., D. Bishop-Bailey, T. Estrada-Hernandez, T. Hla, L. Puddington, and S. J. Padula. 2000. The nuclear receptor PPARγ and immunoregulation: PPARγ mediates inhibition of helper T cell responses. J. Immunol. 164:1364.
35. Yang, X. Y., L. H. Wang, T. Chen, D. R. Hodge, J. H. Resau, L. DaSilva, and W. L. Farrar. 2000. Activation of human T lymphocytes is inhibited by PPARγ agonists: PPARγ co-association with transcription factor NFAT. J. Biol. Chem. 275:4541.
36. Jones, D. C., X. Ding, and R. A. Daynes. 2002. Nuclear receptor PPARα is expressed in resting murine lymphocytes: the PPARα in T and B lymphocytes is both transactivation and transrepression competent. J. Biol. Chem. 277:6838.
37. Faveeuw, C., S. Fougeray, V. Angeli, J. Fontaine, G. Chinetti, P. Gosset, P. Delerive, M. Capron, B. Staels, M. Moser, et al. 2000. PPARγ activators inhibit interleukin-12 production in murine dendritic cells. FEBS Lett. 486:261.
38. Gosset, P., A. S. Charbonnier, P. Delerive, J. Fontaine, B. Staels, J. Pestel, A. B. Tonnel, and F. Trottein. 2001. PPARγ activators affect the maturation of human monocyte-derived dendritic cells. Eur. J. Immunol. 31:2857.
39. Nencioni, A., F. Grunebach, A. Zobywlaski, C. Denzlinger, W. Brugger, and P. Brossart. 2002. Dendritic cell immunogenicity is regulated by PPARγ. J. Immunol. 169:1228.
40. Clark, R. B. 2002. The role of PPARs in inflammation and immunity. 2002. J. Leukocyte Biol. 71:388.
41. Zhang, X., and H. A. Young. 2002. PPAR and immune system: what do we know? Int. Immunopharmacol. 2:1029.
42. Daynes, R. A., and D. C. Jones. 2002. Emerging roles of PPARs in inflammation and immunity. Nat. Rev. Immunol. 2:748.
43. lo thymocytes in vivo. Science 250:1720.
44. Xu, S., P. R. Bergstresser, and A. Takashima. 1995. Phenotypic and functional heterogeneity among murine epidermal-derived dendritic cell clones. J. Invest. Dermatol. 105:831.
45. Xu, S., K. Ariizumi, G. Caceres-Dittmar, D. Edelbaum, K. Hashimoto, P. R. Bergstresser, and A. Takashima. 1995. Colony-stimulating factor-1 secreted by fibroblasts promotes the growth of dendritic cell lines (XS series) derived from murine epidermis. J. Immunol. 154:2697.
46. Roop, D. R., P. Hawley-Nelson, C. Cheng, and S. H. Huspa. 1983. Expression of keratin genes in mouse epidermis and normal and malignantly transformed epidermal cells in culture. J. Invest. Dermatol. 81:144.
47. Schuler, G., and R. M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cell in vitro. J. Exp. Med. 161:526.
48. Shelley, W. B., and L. Juhlin. 1977. Selective uptake of contact allergens by the Langerhans cell. Arch. Dermatol. 113:187.
49. Kripke, M. L., C. G. Munn, A. Jeevan, J. M. Tang, and C. Bucana. 1990. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145:2833.
50. Vermaelen, K. Y., I. Carro-Muino, B. N. Lambrecht, and R. A. Pauwels. 2001. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 193:51.
51. Vremec, D., and K. Shortman. 1997. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159:565.
52. Lambrecht, B. N., R. A. Pauwels, and B. Fazekas De St. Groth. 2000. Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model. J. Immunol. 164:2937.
53. Westergaard, M., J. Henningsen, M. L. Svendsen, C. Johansen, U. B. Jensen, H. D. Schroder, I. Kratchmarova, R. K. Berge, L. Iversen, L. Bolund, et al. 2001. Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. J. Invest. Dermatol. 116:702.
54. Kimber, I., and M. Cumberbatch. 1992. Stimulation of Langerhans cell migration by TNFα. J. Invest. Dermatol. 99:48.
55. Oliver. W. R., J. L. Shenk, M. R. Snaith, C. S. Russell, K. D. Plunket, N. L. Bodkin, M. C. Lewis, D. A. Winegar, M. L. Sznaidman, M. H. Lambert, et al. 2001. A selective PPARδ agonist promotes reverse cholesterol transport. Proc. Natl. Acad. Sci. USA 98:5306.
56. Leesnitzer, L. M., D. J. Parks, R. K. Bledsoe, J. E. Cobb, J. L. Collins, T. G. Consler, R. G. Davis, E. A. Hull-Ryde, J. M. Lenhard, L. Patel, et al. 2002. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41:6640.
57. Kripke, M. L. C. G. Munn, A. Jeevan, J. M. Tang, and C. Bucana. 1990. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145:2833.
58. + T cells. J. Immunol. 15:154:5071.
59. Holt, P. G., S. Haining, D. J. Nelson, and J. D. Sedgwick. 1994. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J. Immunol. 153:256.
60. Langenkamp, A., M. Messi, A. Lanzavecchia, and F. Sallusto. 2000. Kinetics of dendritic cell activation: impact on priming of Th1, Th2 and nonpolarized T cells. Nat. Immunol. 1:311.
61. Ratzinger, G., P. Stoitzner, S. Ebner, M. B. Lutz, G. T. Layton, C. Rainer, R. M. Senior, J. M. Shipley, P. Fritsch, G. Schuler, et al. 2002. Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J. Immunol. 168:4361.
62. Garcia, J. G., A. D. Verin, M. Herenyiova, and D. English. 1998. Adherent neutrophils activate endothelial myosin light chain kinase: role in transendothelial migration. J. Appl. Physiot 84:1817.
63. Ardeshna, K. M., A. R. Pizzey, S. J. Walker, S. Devereux, and A. Khwaja. 2002. The upregulation of CC chemokine receptor 7 and the increased migration of maturing dendritic cells to MIP3β and secondary lymphoid chemokine is mediated by the p38 stress-activated protein kinase pathway. Br. J. Haematol. 119:826.
64. Murphy, G. J., and J. C. Holder. 2000. PPARγ agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol. 21:469.
65. Dubuquoy, L., S. Dharancy, S. Nutten, S. Pettersson, J. Auwerx, and P. Desreumaux. 2002. Role of peroxisome proliferator-activated receptor γ and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 360:1410.